Immunostimulatory Activity of Milife, A Novel Immunomodulator of Fungus Origin

References

• Moser C., Schlesier M., Dragger R., Eibel H., Peter H H. Transient CD80 expression defect in a patient with variable immunodeficiency and cyclic neutropenia. Int. Arch. Allergy. Immunol. 1997; 112: 96
   PubMed Web of Science ®Google Scholar
• Pertuiset E., Beaudreuil J., Horusitzky A., Lioty F., Kemiche F., Richette P, Clerc-Weyl D, Cerf I, Dorfmann H, Glowinski J, Crouzet J, Ziza J M, Bardin T, Meyer O, Dryll A, Kahn M F, Kuntz D. Epidemiological aspects of osteoarticular tuberculosis in adults. Retrospective study of 206 cases diagnosed in the Paris area from 1980 to 1994. Presse Med 1997; 26: 311
   PubMedGoogle Scholar
• Brew B J., Miller J. Human immunodeficiency virus type 1-related transient neurological deficits. Am J Med 1996; 101: 257
   PubMed Web of Science ®Google Scholar
• Hunt C W. Social vs biological: theories on the transmission of AIDS in Africa. Soc Sci Med 1996; 42: 9, 1283
   Web of Science ®Google Scholar
• de Salgado Snyder VN., Dnaz Pyrez M., Maldonado M. AIDS: risk behaviors among rural Mexican women married to migrant AIDS workers in the United States. Educ Prev 1996; 8: 134
   PubMed Web of Science ®Google Scholar
• Sellmeyer D. E., Grunfeld C. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev 1996; 17: 518
   PubMed Web of Science ®Google Scholar
• Ino K, Bierman P. J., Varney M. L., Heimann D. G., Kuszynski C. A., Walker S. A., Talmadge J. E. Monocyte activation by an oral immunomodulator (bestatin) in lymphoma patients following autologous bone marrow transplantation. Cancer Immunol Immunother 1996; 43: 206
   PubMed Web of Science ®Google Scholar
• Karussis D M, Meiner Z, Lehmann D, Gomori J M, Schwarz A, Linde A, Abramsky O. Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide: a double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation. Neurology 1996; 47: 341
   PubMed Web of Science ®Google Scholar
• Kalechman Y, Shani A, Dovrat S, Whisnant J K, Mettinger K, Albeck M, Sredni B. The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinoma. J Immunol 1996; 156: 1101
   PubMed Web of Science ®Google Scholar
• Renoux G, Renoux M. Immune Modulation Agents and Their Mechanisms, Fenichel L. Richard, Chirigos A. Michael. Marcel Dekker, inc., New York 1984; 7
   Google Scholar
• Najjar V. A., Bump N. J. Immune Modulation Agents and Their Mechanisms, Fenichel L. Richard, Chirigos A. Michael. Marcel Dekker, inc., New York 1984; 229
   Google Scholar
• Dozmorov I. M., Bagaeva L. V., Kuzin I. I., Sapozhnikov A. M., Svirshchevskaya E. V., Andronova T. M., Petrov R. V. Muramyl dipeptide - induced changes in murine splenocyte responses to Concanavalin A. Int. J. Immunopharmac. 1992; 14: 159
   PubMed Web of Science ®Google Scholar
• Dozmorov I. M., Bagaeva L. V., Kuzin I. I., Svirshchevskaya E. V. Target cells for immunomodulatory action of muramyl dipeptide. Biomedical Science 1991; 2: 193
   PubMedGoogle Scholar
• Dozmorov I. M., Kuzin I. I., Lutsan N. I., Lutsenko G. V., Prokhorova A. L., Sapozhnikov A. M., Andronova T. M., Ivanov V. T. Comparative study of immunomodulatory properties of muramyl peptides on immune system cells of young and old mice. Immunopharmacology and immunotoxicology 1994; 16: 149
   PubMed Web of Science ®Google Scholar
• Mikhialova A. A., Fonina L. A., Kirilina E., Shanurin S., Guriyanov S., Malakhov A., Nesmeyanov V., Petrov R. V. Immunoregulatory properties of hexapeptide isolated from porcine bone marrow cell culture. Regulatory peptides 1994; 53: 203
   PubMedGoogle Scholar
• Petrov R. V., Mikhailova A. A., Fonina L. A. Myelopeptides: bone marrow regulatory mediators. Bioscience Reports 1995; 15: 1
   PubMed Web of Science ®Google Scholar
• Mikhailova A. A., Shanurin S. Y., Petrov R. V. Immunoregulatory effects of two bone-marrow hexapeptides (myelopeptides) in experimental models of immunodeficiency. Immun. Let. 1995; 47: 199
   PubMed Web of Science ®Google Scholar
• Strelkov L. A., Mikhailova A. A., Sapozhnikov A. M., Fonina L. A., Petrov R. V. The bone marrow peptide (myelopeptide-2) abolishes induced by human leukemia HL-60 cell suppression of T-lymphocytes. Immun. Let. 1996; 50: 143
   PubMed Web of Science ®Google Scholar
• Aoki T. Immune Modulation Agents and Their Mechanisms, Fenichel L. Richard, Chirigos A. Michael. Marcel Dekker, inc., New York 1984; 63
   Google Scholar
• Reisenstein P., Mathe G. Immune Modulation Agents and Their Mechanisms, Fenichel L. Richard, Chirigos A. Michael. Marcel Dekker, inc., New York 1984; 347
   Google Scholar
• Tanaka S., Ko K., Tsuchiya K., Yamashita A., Murasugi A., Sakuma S., Tsunoo H. Complete amino acid sequence of an immunomodulatory protein, ling zhi-8 (LZ-8). An immunomodulator from a fungus, Ganoderma lucidium, having similarity to immunoglobulin variable regions. J. Biol. Chem. 1989; 264: 16372
   PubMed Web of Science ®Google Scholar
• Svirshchevskaya E. V., Viskova N. Y., Sapozhnikov A. M., Dizha V. I., Kucherova I. V. Immunomodulating properties of higher fungus Fuzarium extract. Immunologiya (in Russian) 1997; 2: 29
   Google Scholar
• International application index of laboratory animals. Medical research council laboratory animals centre, 6th edition, M. F. W. Festing, United Kingdom 1993; 22
   Google Scholar
• Kramnik I. B., Moiseeva E. V., Slatinova O. V. Research news. Mouse newsletter. 1989; 85: 10
   Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983; 65: 55
   PubMed Web of Science ®Google Scholar
• Freitas A. A., Rocha B. B. Lymphocyte population kinetics: a cellular competition model. Autoimmunity: Physiology and Disease, A. Coutnho, M. D. Kazatchkine. Wiley-Liss, Inc. 1994; 143
   Google Scholar